NASDAQ:PRCT PROCEPT BioRobotics (PRCT) Stock Price, News & Analysis $76.60 +0.25 (+0.33%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$71.72▼$76.6050-Day Range$56.31▼$83.4452-Week Range$24.83▼$85.81Volume790,025 shsAverage Volume594,117 shsMarket Capitalization$3.94 billionP/E RatioN/ADividend YieldN/APrice Target$74.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get PROCEPT BioRobotics alerts: Email Address PROCEPT BioRobotics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside3.2% Downside$74.17 Price TargetShort InterestBearish11.60% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 10 Articles This WeekInsider TradingSelling Shares$6.10 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.88) to ($1.47) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.50 out of 5 starsMedical Sector857th out of 910 stocksSurgical & Medical Instruments Industry92nd out of 95 stocks 1.5 Analyst's Opinion Consensus RatingPROCEPT BioRobotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoveragePROCEPT BioRobotics has only been the subject of 3 research reports in the past 90 days.Read more about PROCEPT BioRobotics' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.60% of the float of PROCEPT BioRobotics has been sold short.Short Interest Ratio / Days to CoverPROCEPT BioRobotics has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in PROCEPT BioRobotics has recently increased by 8.41%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPROCEPT BioRobotics does not currently pay a dividend.Dividend GrowthPROCEPT BioRobotics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRCT. Previous Next 2.5 News and Social Media Coverage News SentimentPROCEPT BioRobotics has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for PROCEPT BioRobotics this week, compared to 4 articles on an average week.Search Interest11 people have searched for PRCT on MarketBeat in the last 30 days. This is an increase of 120% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added PROCEPT BioRobotics to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PROCEPT BioRobotics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,096,228.00 in company stock.Percentage Held by Insiders17.40% of the stock of PROCEPT BioRobotics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions89.46% of the stock of PROCEPT BioRobotics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PROCEPT BioRobotics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for PROCEPT BioRobotics are expected to grow in the coming year, from ($1.88) to ($1.47) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PROCEPT BioRobotics is -36.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PROCEPT BioRobotics is -36.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPROCEPT BioRobotics has a P/B Ratio of 13.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about PROCEPT BioRobotics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About PROCEPT BioRobotics Stock (NASDAQ:PRCT)PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.Read More PRCT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRCT Stock News HeadlinesSeptember 6 at 8:35 AM | insidertrades.comInsider Selling: PROCEPT BioRobotics Co. (NASDAQ:PRCT) Director Sells 13,305 Shares of StockAugust 14, 2024 | marketbeat.comIs PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasiaSeptember 7, 2024 | Mode Mobile (Ad)Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.September 7 at 5:41 AM | americanbankingnews.comAntal Rohit Desai Sells 35,220 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) StockSeptember 4 at 3:34 AM | americanbankingnews.comPROCEPT BioRobotics (NASDAQ:PRCT) Given New $95.00 Price Target at Truist FinancialAugust 30, 2024 | msn.comDo You Believe in the Growth Prospects of PROCEPT BioRobotics (PRCT)?August 30, 2024 | americanbankingnews.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of "Buy" by BrokeragesAugust 29, 2024 | ca.finance.yahoo.comPRCT Apr 2025 70.000 callSeptember 7, 2024 | Mode Mobile (Ad)Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.August 29, 2024 | ca.finance.yahoo.comPRCT Oct 2024 120.000 callAugust 28, 2024 | globenewswire.comPROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024August 28, 2024 | americanbankingnews.comBank of America Boosts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $94.00August 28, 2024 | americanbankingnews.comBank of America Raises PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $94.00August 27, 2024 | seekingalpha.comProcept BioRobotics: Risk Capital Unlock With FDA Hydros ApprovalAugust 23, 2024 | markets.businessinsider.comPROCEPT BioRobotics (PRCT) Gets a Buy from Truist FinancialAugust 22, 2024 | markets.businessinsider.comBuy Rating Justified: PROCEPT BioRobotics’s Technological Innovation and Market Growth PotentialAugust 22, 2024 | finance.yahoo.comPROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® TherapyAugust 21, 2024 | globenewswire.comPROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® TherapySee More Headlines Receive PRCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PROCEPT BioRobotics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/01/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PRCT CUSIPN/A CIK1588978 Webwww.procept-biorobotics.com Phone650-232-7200FaxN/AEmployees430Year FoundedN/APrice Target and Rating Average Stock Price Target$74.17 High Stock Price Target$95.00 Low Stock Price Target$37.00 Potential Upside/Downside-3.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($2.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-105,900,000.00 Net Margins-58.73% Pretax Margin-58.74% Return on Equity-37.85% Return on Assets-26.20% Debt Debt-to-Equity Ratio0.20 Current Ratio7.51 Quick Ratio6.49 Sales & Book Value Annual Sales$176.58 million Price / Sales22.31 Cash FlowN/A Price / Cash FlowN/A Book Value$5.56 per share Price / Book13.78Miscellaneous Outstanding Shares51,424,000Free Float42,476,000Market Cap$3.94 billion OptionableOptionable Beta1.03 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Reza Zadno Ph.D. (Age 69)President, CEO & Director Comp: $1.13MMr. Kevin Waters (Age 47)Executive VP & CFO Comp: $680.11kMs. Alaleh Nouri (Age 45)EVP, Chief Legal Officer & Corporate Secretary Comp: $605.84kMr. Hisham Shiblaq (Age 48)Executive VP & Chief Commercial Officer Comp: $645.95kMr. Mohan F. Sancheti (Age 60)Senior Vice President of Operations Mr. Barry TemplinExecutive VP of Technology & Clinical DevelopmentMr. Matthew James Bacso C.F.A.Vice President of Investor RelationsMs. Stacey L. Porter (Age 48)Chief People Officer Mr. Bijesh ChandranSenior Vice President of Regulatory Affairs & Quality AssuranceMore ExecutivesKey CompetitorsAtrionNASDAQ:ATRINano-X ImagingNASDAQ:NNOXInogenNASDAQ:INGNBionano GenomicsNASDAQ:BNGOVapothermNYSE:VAPOView All CompetitorsInsiders & InstitutionsAntal Rohit DesaiSold 13,305 sharesTotal: $1.02 M ($76.37/share)Antal Rohit DesaiSold 35,220 sharesTotal: $2.68 M ($76.12/share)Driehaus Capital Management LLCBought 71,930 shares on 8/16/2024Ownership: 0.679%Algert Global LLCBought 27,027 shares on 8/16/2024Ownership: 0.053%Creative PlanningBought 5,267 shares on 8/16/2024Ownership: 0.010%View All Insider TransactionsView All Institutional Transactions PRCT Stock Analysis - Frequently Asked Questions How have PRCT shares performed this year? PROCEPT BioRobotics' stock was trading at $41.91 at the beginning of the year. Since then, PRCT shares have increased by 82.8% and is now trading at $76.60. View the best growth stocks for 2024 here. How were PROCEPT BioRobotics' earnings last quarter? PROCEPT BioRobotics Co. (NASDAQ:PRCT) released its earnings results on Thursday, August, 1st. The company reported ($0.50) EPS for the quarter, beating analysts' consensus estimates of ($0.52) by $0.02. PROCEPT BioRobotics's revenue for the quarter was up 61.2% on a year-over-year basis. When did PROCEPT BioRobotics IPO? PROCEPT BioRobotics (PRCT) raised $126 million in an initial public offering on Wednesday, September 15th 2021. The company issued 5,500,000 shares at a price of $22.00-$24.00 per share. Who are PROCEPT BioRobotics' major shareholders? Top institutional shareholders of PROCEPT BioRobotics include CPMG Inc (1.86%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.01%), Blair William & Co. IL (0.81%) and Massachusetts Financial Services Co. MA (0.78%). Insiders that own company stock include Frederic H Moll, Antal Rohit Desai, Reza Zadno, Morgan Colby Wood, Kevin Waters, Hisham Shiblaq, Alaleh Nouri and Global Investors Lp Viking. View institutional ownership trends. How do I buy shares of PROCEPT BioRobotics? Shares of PRCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRCT) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRCT Stock Alerts